These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 15677382)

  • 1. The importance of considering the effects of perceived group assignment in placebo-controlled trials.
    Benedetti F
    Eval Health Prof; 2005 Mar; 28(1):5-6. PubMed ID: 15677382
    [No Abstract]   [Full Text] [Related]  

  • 2. Control group bias in randomized atypical antipsychotic medication trials for schizophrenia.
    Woods SW; Gueorguieva RV; Baker CB; Makuch RW
    Arch Gen Psychiatry; 2005 Sep; 62(9):961-70. PubMed ID: 16143728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Placebo surgery in trials of therapy for Parkinson's disease.
    Horisberger JD
    N Engl J Med; 2000 Feb; 342(5):354-5. PubMed ID: 10660399
    [No Abstract]   [Full Text] [Related]  

  • 4. Placebo: new insights into an old enigma.
    Ernst E
    Drug Discov Today; 2007 May; 12(9-10):413-8. PubMed ID: 17467578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blinding protocols, treatment credibility, and expectancy: methodologic issues in clinical trials of osteopathic manipulative treatment.
    Licciardone JC; Russo DP
    J Am Osteopath Assoc; 2006 Aug; 106(8):457-63. PubMed ID: 16943515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unsubstantiated claims of large effects of placebo on pain: serious errors in meta-analysis of placebo analgesia mechanism studies.
    Hróbjartsson A; Gøtzsche PC
    J Clin Epidemiol; 2006 Apr; 59(4):336-8; discussion 339-41. PubMed ID: 16549252
    [No Abstract]   [Full Text] [Related]  

  • 7. Is the placebo powerless?
    Einarson TE; Hemels M; Stolk P
    N Engl J Med; 2001 Oct; 345(17):1277; author reply 1278-9. PubMed ID: 11680456
    [No Abstract]   [Full Text] [Related]  

  • 8. Prevalence and factors associated with use of placebo control groups in randomized controlled trials in psoriasis: a cross-sectional study.
    Katz KA; Karlawish JH; Chiang DS; Bognet RA; Propert KJ; Margolis DJ
    J Am Acad Dermatol; 2006 Nov; 55(5):814-22. PubMed ID: 17052487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design of randomized controlled trials.
    Stanley K
    Circulation; 2007 Mar; 115(9):1164-9. PubMed ID: 17339574
    [No Abstract]   [Full Text] [Related]  

  • 10. A pilot seminar on ethical issues in clinical trials for cancer researchers in Vietnam.
    Love RR; Fost N
    IRB; 2003; 25(6):8-10. PubMed ID: 15035249
    [No Abstract]   [Full Text] [Related]  

  • 11. Trial methodology and patient characteristics did not influence the size of placebo effects on pain.
    Kamper SJ; Machado LA; Herbert RD; Maher CG; McAuley JH
    J Clin Epidemiol; 2008 Mar; 61(3):256-60. PubMed ID: 18226748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is the placebo powerless?
    Kupers R
    N Engl J Med; 2001 Oct; 345(17):1278; author reply 1278-9. PubMed ID: 11680457
    [No Abstract]   [Full Text] [Related]  

  • 13. Harmful effects of the placebo-controlled design.
    Berthelot JM; Glemarec J; Lopes L; Guillot P; Maugars Y; Prost A
    Rev Rhum Engl Ed; 1998 Jan; 65(1):41-3. PubMed ID: 9523385
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment allocation in clinical trials.
    Webert KE
    Transfusion; 2007 Dec; 47(12):2187-8. PubMed ID: 17714423
    [No Abstract]   [Full Text] [Related]  

  • 15. Local IRBs, multicenter trials, and the ethics of internal amendments.
    Jansen LA
    IRB; 2005; 27(4):7-11. PubMed ID: 16220628
    [No Abstract]   [Full Text] [Related]  

  • 16. Who controls the placebo? Introducing a Placebo Quality Checklist for pharmacological trials.
    Brinkhaus B; Pach D; Lüdtke R; Willich SN
    Contemp Clin Trials; 2008 Mar; 29(2):149-56. PubMed ID: 17669693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monitoring clinical trials. Several points are contentious.
    Parry D
    BMJ; 2001 Dec; 323(7326):1425. PubMed ID: 11778590
    [No Abstract]   [Full Text] [Related]  

  • 18. Dropout rates in placebo-controlled and active-control clinical trials of antipsychotic drugs: a meta-analysis.
    Kemmler G; Hummer M; Widschwendter C; Fleischhacker WW
    Arch Gen Psychiatry; 2005 Dec; 62(12):1305-12. PubMed ID: 16330718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Placebo or intervention? Is it all a sham?
    Sites BD; Neal JM
    Anaesthesia; 2011 Feb; 66(2):73-5. PubMed ID: 21254979
    [No Abstract]   [Full Text] [Related]  

  • 20. On non-inferiority margin and statistical tests in active control trials.
    Chow SC; Shao J
    Stat Med; 2006 Apr; 25(7):1101-13. PubMed ID: 16345042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.